



  O R I G I N A L  S C I E N T I F I C  P A P E R    
 
 
 Croat. Chem. Acta 2015, 88(3), 213–219 
 Published online: December 30, 2015 




Interaction of Insulin and 
Polymer Surface Investigated by 
Surface-MALDI-TOF-Mass Spectrometry 
 
Zahida Ademović,1,* Jochen Salber,2 and Doris Klee3 
 
 
1 Faculty of Technology, University of Tuzla, Univerzitetska 8, 75000 Tuzla, Bosnia and Herzegovina 
2 Chirurgische Klinik und Poliklinik, BG Universitaetsklinikum Bergmannsheil, Ruhr-University Bochum, Germany 
3 Department of Textile Chemistry and Macromolecular Chemistry, RWTH Aachen, Pauwelsstr. 8, 52074 Aachen, Germany 
* Corresponding author’s e-mail address: zahida.ademovic@untz.ba 
 
RECEIVED: July 14, 2014    REVISED: February 23, 2015    ACCEPTED: April 17, 2015 
 
 
Abstract: Synthetic materials in contact with protein containing solution adsorb a considerable amount of proteins. The adsorption behaviour 
of zinc-free porcine insulin on the hydrophobic poly(vinylidene fluoride) (PVDF) surfaces before and after chemical vapour deposition (CVD) 
modification was directly analysed by matrix-assisted laser desorption ionisation-time-of-flight-mass spectroscopy in surface mode (surface-
MALDI-TOF-MS). The MALDI mass spectra of Zn-free porcine insulin dissolved in carbonate buffer pH 8.3 after adsorption onto non-modified 
and modified PVDF-CVD surfaces contain peaks assigned to monomer ion peak as well as peaks that are results of degradation of Zn-free 
porcine insulin. The degradation is caused by structural changes taking place during adsorption of insulin onto hydrophobic surfaces and by 
subsequent laser induced desorption and ionisation process. Surface spectra of Zn-free porcine insulin dissolved in deionised water show only 
monomer ion peaks of porcine insulin without degradation product detected. Structure stability of Zn-free porcine insulin upon adsorption is 
influenced by hydrophobic interaction between insulin and the surface. 
 





ANY synthetic surfaces adsorb proteins when ex-
posed to protein-containing solutions. These inter-
face-related phenomena is important to understand the 
processes taking place in, for example, chromatographic 
separation of proteins, detection assays for biomolecules, 
fouling of membranes, compatibility of biomaterials and 
protein aggregation.[1,2] Also, materials used for administra-
tion of proteins in pharmaceutical dosage forms adsorb a 
considerable amount of protein and thus poses a risk factor 
for unsteady dosage of proteins.[3] The protein adsorption 
process is complex and is still not fully understood. The rate 
and amount of adsorbed protein are dependent on the 
physico-chemical properties of the polymeric surface such 
as wettability and surface charge density. In general, ad-
sorption behaviour of proteins is governed by electrostatic 
and hydrophobic interactions between protein and the 
solid surface.[4,5] Proteins adsorbed on surfaces may un-
dergo structural changes upon adsorption and the adsorp-
tion process is crucial for biocompatibility of the synthetic 
material. Therefore surface modification procedures are 
developed to create ultrathin interfaces at the implant sur-
faces which will control protein adsorption process. 
 Poly(vinylidene fluoride) (PVDF) has been employed 
as a biomaterial due to its nontoxicity, extraordinary dura-
bility and chemical stability.[6] The coating of PVDF by chem-
ical vapour deposition (CVD) polymerisation process using 
functionalised paracyclophane enables the introduction of 
functional groups (e.g. amino groups) in a single solvent-
free step. The understanding of the interaction which takes 
place between the modified PVDF surface and the compo-
nents of the biological system is an important requirement 
of biomaterial development. 
 A number of techniques are available for studying pro-
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and radiolabelling methods.[9,10] For these techniques a 
large amount of proteins and a highly specific surface area 
are necessary to measure adsorbed proteins and receive 
enough signals. A method allowing the direct analysis of 
proteins adsorbed on surfaces would therefore be more 
useful. Molecular ions of complex molecules can readily be 
observed in the mass spectra obtained by the technique of 
matrix-assisted laser desorption ionisation (MALDI) in the 
time-of-flight (TOF) mode. MALDI can determine the mole-
cular weight of proteins up to a few hundred kilodaltons[11] 
with a high mass resolution and very low detection limits.[12] 
Standard MALDI-TOF-MS spectra have been obtained after 
an analyte is dispersed at low concentration in a photoab-
sorbing matrix and are co-crystallized with it.[13] A laser shot 
decomposes the layer of matrix and eject the proteins 
which are ionized. The ionization, usually obtained by pro-
tonation, allows to accelerate the protein ions and to meas-
ure their mass to charge ratio. MALDI-TOF-MS in surface 
mode has been developed to detect molecular ions of ana-
lytes which are adsorbed onto material surface.[14] MALDI-
TOF-MS offers one of the simplest, rapid and most efficient 
methods for the analysis of surface-bound proteins. 
 The main interest in studying adsorption of insulin 
onto interfaces has been based on the use of the protein in 
various drug delivery systems to obtain controlled release 
administration, where the major focus has been on interac-
tions of insulin with solid/liquid interfaces occurring in 
pump devices and on prevention of fibrillation.[15] The pro-
tein conformation can be altered upon adsorption which in 
turn affects the biological function of the protein. Among 
other physical interactions responsible for protein adsorp-
tion, it is often found that hydrophobic interactions have a 
distinct effect on protein conformation.[16] 
 In this study, the interaction of Zn-free porcine insu-
lin physically adsorbed onto solid PVDF polymer surfaces 
was studied. The adsorption behaviour of Zn-free porcine 
insulin in aqueous and buffered solution on the polymer 
surfaces with different hydrophobicity was analysed. 
 
MATERIALS AND METHODS 
Surface Preparation 
Poly(vinylidene) fluoride (PVDF) was purchased from Solvay 
Adv. Polym. (France). PVDF granulate was pressed at 190 °C 
for 10 min to obtain films and purified by Soxhlet extraction 
with hexane/ethanol. 
 The coating of PVDF by chemical vapour deposition 
(CVD) polymerisation process using functionalised paracy-
clophane was carried out in a self-designed machine by the 
method described elsewhere.[17] Briefly the monomer 4-
Amino[2.2]-paracyclophane was pyrolyzed at 650 °C under 
reduced pressure and than condensed at 18 °C on PVDF. Af-
ter the procedure we had surfaces coated with poly[o-
amino-p-xylylene-co-p-xylylene] (PVDF-CVD). 
 Contact angles were measured in ultrapure water us-
ing the sessile drop method at room temperature on a G40 
system (Krüss, Germany). 
Insulin Adsorption 
Porcine insulin was obtained from Aventis (USA) and was 
cleared from zinc using gel chromatography (Sephadex G 
25). Zinc free insulin was dissolved in a 0.1 M carbonate 
buffer pH 8.3 or in deionised water to an end concentration 
of 1 mg/ml. Surfaces were incubated in insulin solution for 
1 h at 37 °C and rinsed twice with carbonate buffer and 
twice with deionised water. Surfaces incubated in deionised 
water were rinsed only with deionised water to remove 
weakly and non-adsorbed insulin. Reference surface spec-
tra were obtained by incubating nonmodified PVDF in insu-
lin solution for 1 h at 37 °C without subsequent washing. 
Finally, surfaces were dried under ambient conditions. 
Surface-MALDI-TOF-MS Analysis 
Surface-MALDI-TOF-mass spectra were obtained using a 
BRUKER BIFLEXTM III MALDI time-of-flight mass spectrome-
ter (Bruker-Franzen Analytik, Germany) equipped with a 
SCOUT-ion source, an ion mirror (reflectron) and standard-
microchannel-plate-detectors. The instrument was used 
with a variable accelerating voltage up to 20 kV and operat-
ing in reflection mode. A pulsed nitrogen laser (337 nm 
wavelength and 3 ns pulse width) was used for matrix crys-
tal deposition. The laser power was adjusted between 
50−70 % of its maximum. For each spectrum 100−150 shots 
were summed. The instrument control and data processing 
were accomplished with the software Bruker XTOF 3.1.0 
supplied by Bruker. 
 In present experiments a small sample piece cut from 
PVDF and PVDF-CVD surfaces after adsorption with insulin 
were placed onto the stainless steel MALDI sample holder. 
Sinapinic acid in a 0.1 % solution of trifluoroacetic acid in 
acetonitrile/water was applied onto the sample surface. Be-
fore inserting the sample holder into the spectrometer the 
solvent was evaporated. Thereafter, pulsed UV laser irradi-
ation causes volatilisation of matrix crystals and the embed-
ded protein molecules, which were ionised, extracted and 
detected in standard MALDI-MS fashion. 
 
RESULTS AND DISCUSSION 
Porcine insulin is a small globular protein with a molecular 
mass of 5777 Da and is composed of a A-polypeptide chain 
(21 amino acids) which contains an intrachain disulfide bond 
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which contains two interchain disulfide bonds. The full 
amino acid sequence of porcine insulin is shown in Figure 1. 
 Crystallographic studies indicate that insulin contains 
three α-helices (two located in the A−chain at posiƟon 
A1−A9 and A12−A19 and one located in B-chain at position 
B9−B19).[18] However, the insulin structure is highly dy-
namic, with the N-terminal (B1−B8) and C-terminal seg-
ments (B25−B30) of the B-chain having the greatest 
flexibility[19] (Figure 2). 
 The insulin monomer has nonpolar amino acids ex-
posed to the medium, which is not thermodynamically fa-
vorable and the equilibrium constant for the formation of 
dimers is high.[20] The dimer is generally recognized as the 
predominant starting species. At higher insulin concentra-
tions three dimers joins together into a hexamer. Other fac-
tors that affect the self-association of insulin are pH, ionic 
strength and the presence of certain divalent ions. When 
the two monomers are associated a shared antiparallel β-
sheet structure is formed between the two C-terminal 
strands of the B-chain.[22] This shared structure makes the 
monomer–monomer interaction stronger than the interac-
tions involved in the formation of tetrameric and hexameric 
states of insulin. The formation of the hexamer results in 
the burial of nonpolar amino acids within the core of the 
hexamer. Those nonpolar amino acids are otherwise ex-
posed on the surface of the dimer. The hexamer is there-
fore the most hydrophilic species of insulin. 
 The multimerization and aggregation of insulin are of 
great importance in biology, pharmacology, and protein fi-
brilogenesis. Insulin is stored in the pancreas as the inactive 
zinc hexamer. When released into the blood serum by the 
pH change, this hexamer dissociates into a dimer and then 
subsequently into a monomer, which is its physiologically 
active form. However, the insulin monomer is less stable 
than the hexamer and tends to aggregate. Under physiolog-
ical conditions, Zn-insulin shows reduced fibril formation 
relative to Zn-free insulin because of the formation of the 
stable Zn-insulin hexamer.[23] The effect of Zn2+ on multimer 
equilibria is dramatic because of the formation a stable Zn-
insulin complex, thought to arise from the combination of 
two Zn ions with three native conformation insulin di-
mers.[24] 
 Insulin interacts weakly with hydrophilic surfaces, 
whereas stronger interaction are present with hydrophobic 
surfaces at neutral pH.[25] The first stages in the adsorption 
process involve transport of the protein to the surface, dep-
osition and subsequently unfolding or spreading of the pro-
tein to thermodynamically more stable conformations. 
Since the monomeric and dimeric forms are the most hy-
drophobic species, they are expected to be the species 
most prone to adsorption. The monomer is the least stable 
species in solution and that interfacial aggregation is initial-
ized by adsorption of the monomer.[26] Other insulin species 
interact with the interface in a reversible manner, but the 
monomer may unfold irreversibly at the interface, which 
could be the first step in the aggregation pathway. 
 In present work, surface-MALDI-TOF-MS was used to 
directly analyse porcine insulin that was physically ad-
sorbed onto PVDF surfaces before and after CVD modifica-
tion. These surfaces differ in hydrophobicity. The contact 
angle measurement by sessile drop method shows the hy-
drophobic nature of both PVDF surface. Contact angle of 
untreated PVDF is 83° and this value increase to 92° after 
modification of the surface using CVD polymerisation pro-
cess. This increasing is caused by aromatic rings from de-
posited CVD polymer layer. 
 
Figure 1. The chemical sequence of the porcine insulin. 
 
Figure 2. Ribbon drawing of the monomeric porcine insulin 
secondary structure, including disulfide bonds. A-chain is 
striped. Helices are spirals, the beta sheet is an arrow and 
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 Figure 3 shows the positive MALDI spectra of 1 
mg/ml Zn-free porcine insulin dissolved in carbonate buffer 
pH 8.4 and subsequently adsorbed onto different PVDF sur-
faces. All spectra showed a strong protonated monomer ion 
peak (1) at m/z value 5745 which corresponds to proto-
nated monomer ion [M+H]+. This peak is joined on the right 
side by a small adduct peak (2) created by the binding of 
insulin with a matrix molecule. Also, an insulin double 
charged monomer ion peak (4) at m/z value 2880 is ob-
served, which corresponds to [M+2H]2+. Interestingly, in 
Figures 3b and 3c an additional peak (3) is shown which is 
not detected in the reference surface spectrum of porcine 
insulin (Figure 3a). Additionally, in the spectrum of porcine 
insulin adsorbed on PVDF-CVD surface other peaks (5), (6) 
and (7) are detected (Figure 3c). 
 The determination of the mass difference between 
the monomer ion peak (1) and degradation peak (3) varies 
generally between 260 and 310 Da. The mass difference be-
tween double charged ion peak (4) and degradation peak 
(5) ranges from 130 to 260 Da. The peaks (6) are detected 
between 4200 and 4300 Da and peak (7) between 4750 and 
4830 Da. The exact determination of m/z of the additional 
degradation peaks is not possible as the variations in sam-
ple preparation and the instrumental resolution resulted in 
a broadening of mass peaks of insulin samples.[27] Addition-
ally, MALDI measurements in surface mode of biomolecules 
is performed on solid carriers of undefined thickness, there-
fore the mass scale is shifted because the TOF detector is 
calibrated for sample analysis using standard sample hold-
ers. By sticking a piece of PVDF onto the sample holder, the 
ion path is slightly shorter, which causes an indeterminable 
shift in the m/z classification.[14] 
 It is likely that sensitive MALDI detection of adsorbed 
biomolecules depends on desorption of analyte from the 
surface by matrix and at the same time an effective incor-
poration of the analyte molecules into the matrix crystals. 
In the standard MALDI technique protein analytes are dis-
persed in solution together with matrix molecules and con-
sequently good mixing and incorporation of the analyte into 
the growing matrix crystals after evaporation of the sol-
vents is achieved. In the MALDI-surface mode, matrix mol-
ecules are added on the protein (analyte) layer that is 
adsorbed on the polymer surface. Therefore, protein mole-
cules need to be desorbed from the surface and incorpo-
rated into the growing matrix crystals. Because protein 
molecules must be first desorbed off the solid surface and 
then dispersed in the matrix crystals, the interaction be-
tween protein and solid surface as well as interaction be-
tween protein and matrix must be considered. If the matrix 
is not able to desorb and encapsulate protein molecule 
completely, some part of protein molecule remains unpro-
tected by matrix and is exposed to laser energy. It should 
be taken in account that only the most tightly bound insulin 
 
Figure 3. MALDI-TOF mass spectra of 1 mg/ml Zn-free 
porcine insulin in carbonate buffer pH 8.3 adsorbed on a) 
PVDF without washing (reference), b) insulin adsorbed on 
PVDF surface and c) insulin adsorbed on PVDF-CVD surface. 
Spectra: peak (1) - protonated monomer ion [M+H]+, peak 
(2) - binding of insulin with a matrix molecule, peak (3, 5, 6, 
7) – degradation peaks, peak (4) - insulin double charged 
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molecules in Figure 3b and 3c were analysed because less 
strongly adsorbed insulin were desorbed and washed away 
before analysing the samples. Some studies have demon-
strated that strongly surface-bound peptides are ineffi-
ciently ionised in MALDI experiments, presumably due to 
the incomplete and poor incorporation of the protein into 
the MALDI matrix crystals.[28] 
 The spectra of porcine insulin adsorbed on PVDF sur-
face (Figure 3b) shows only a weak degradation peak (3) in 
comparison to PVDF-CVD surface (Figure 3c). On PVDF-CVD 
surface in addition to a strong degradation peak (3), the 
peaks (4), (5) and (6) are observed. These peaks belong to 
degradation products of porcine insulin caused by MALDI 
laser-induced desorption and ionisation process. Porcine 
insulin molecules are strongly adsorbed on the hydrophobic 
surface and are incapable to desorbs and incorporate in the 
crystal matrix during MALDI desorption and ionisation pro-
cess. This implies that the insulin structure is largely desta-
bilised upon adsorption onto hydrophobic surfaces, thus 
illustrating the general observation that hydrophobic inter-
actions have a relatively strong effect on the protein con-
formation. The strong interaction of insulin with the 
hydrophobic surface is accompanied by a strong reduction 
in its structural stability compared to the stability in solu-
tion.[24] This effect is more pronounced for more hydropho-
bic PVDF-CVD surface in comparison to less hydrophobic 
PVDF surface. 
 Regarding the mass differences between the peaks, 
the degradation products that belong to the peak (3) and 
peak (5) could come from either the first three amino acids 
at the N-terminus of the A-chain or the last three amino ac-
ids at the C-terminus of the B-chain, assuming that these 
sequences were cleaved during laser desorption and ionisa-
tion process. The three hydrophobic amino acids A1−A3 
(Gly-Ile-Val) are in a relative fixed conformation state re-
garding to their affiliation to the helical part of the N-termi-
nus of the A-chain. It is very probably that the strong 
hydrophobic amino acids B24−B26 (Phe-Phe-Tyr) in the 
beta sheet forming sequence (Figure 1) adsorb onto the hy-
drophobic solid surface to form very strong hydrophobic in-
teraction. The high flexible and hydrophilic C-terminus of 
the B-chain (B28−B30) remains free (Figure 2). Conse-
quently the MALDI matrix solution is not able to desorb 
completely the porcine insulin molecule and thus co-crys-
tallisation of the whole porcine insulin molecule with matrix 
molecules is not ensured. Presumably a part of insulin is in-
complete incorporated in the matrix. We postulated here 
that the flexible part of B-chain (B28−B30) remains unpro-
tected by matrix and is exposed to laser energy. The high 
intensity of laser energy breaks the peptide bond between 
B27 and B28. The resulting degradation product is seen in 
Figure 3b and 3c as peaks (3). The peaks (6) and (7) are not 
 
Figure 4. MALDI-TOF mass spectra of 1mg/ml Zn-free 
porcine insulin in deionised water pH 4.3 adsorbed on a) 
PVDF without washing (reference), b) insulin adsorbed on 
PVDF surface and c) insulin adsorbed on PVDF-CVD surface. 
Spectra: peak (1) − protonated monomer ion [M+H]+, peak 
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characterized yet. Further investigation is required to affirm 
our assumption and to identify the non characterised 
peaks. In the non-washed reference surface spectrum (Fig-
ure 3a) the peaks of the degradation products are not de-
tected, because porcine insulin adsorbed from a 1 mg/ml 
solution forms a multilayer onto the PVDF surface. There-
fore, only less bound insulin molecules incorporated in mul-
tilayer coverage of the surface that are not directly 
adsorbed to the hydrophobic surface are desorbed and 
were able to completely associate with matrix crystals dur-
ing preparation. 
 Examples of the positive MALDI mass spectra of 1 
mg/ml Zn-free porcine insulin, which was dissolved in de-
ionised water and subsequently adsorbed onto the PVDF 
and PVDF-CVD surfaces, are shown in Figure 4. In contrast 
to Figure 3 all spectra display a strong monomer ion peak 
(1) corresponding to [M+H]+ and a porcine insulin double 
charged ion peak (4) which corresponds to [M+2H]2+. No 
degradations peaks are detected. 
 The insulin behaviour in solution at different concen-
tration and pH could explain these results. Insulin exists in 
equilibrium between monomer, dimer and hexamer. The de-
gree of association is highly influenced by the concentration 
and type of insulin. This may also influence stability and es-
pecially adsorption. It has been shown that the Zn-free hu-
man insulin at concentrations above 1 mg/ml is in a 70 % 
dimer and 30 % monomer form. At concentrations below 0.1 
mg/ml, at pH 7.4 only monomers are found.[29] Other have 
observed mainly monomers below concentrations of 3 
mg/ml for various insulin variants.[30] The structure would be 
expected to vary if the protein adsorbed to the surface was 
either monomer or a combination of monomer, dimer or 
even hexamer. The packing and the available space on the 
surface to accommodate structural changes would vary, as 
would the ratio of monomer to dimer. The exposure of hy-
drophobic area at the protein surface also varies depending 
on the presence and distribution of monomer to dimer to 
hexamer and this in turn could influence both the adsorption 
and the structural changes upon adsorption. The structure of 
adsorbed protein does differ from that in solution, and many 
proteins also tend to form more β-sheet structure upon ad-
sorption or lose structural elements such as α-helix.[31,32] 
 In solution at neutral pH and at low concentration in-
sulin exists as a monomer.[33] At higher concentrations at 
acidic or neutral pH in absence of zinc the insulin monomer 
self-associates to form dimmers in which only intermolecu-
lar forces between the molecules are presented.[34] It should 
be taken in account that the Zn-free insulin used in this ex-
periment contains a considerable amount of acetic acid so 
that the zinc-free insulin disolved in deionised water has an 
acidic pH 4.3. In addition, the concentration of the solution is 
very high (1 mg/ml). Therefore, we assume that porcine insu-
lin under these condition forms dimers. The MALDI  
matrix solution is able to desorbs and completely encapsu-
late the porcine insulin molecules from dimer layer. 
 Monomer as well as dimer and hexamer can adsorb 
to the surface. It has been described that the insulin mono-
mer is the least stable of these three conformations and is 
most likely to change conformation upon adsorption to a 
hydrophobic surface.[35] Therefore, the monomer would 
undergo structural changes, whereas dimer and hexamer 
would not. Furthermore, it has been indicated that the 
monomer is the species with the highest tendency to ad-
sorb to hydrophobic surfaces.[36] Therefore, the distribution 
between monomer, dimer and hexamer, which is highly de-
pendent on concentration, zinc content and type of insulin, 
could have an effect on adsorption.[37] 
 It is assumed that Zn-free porcine insulin is adsorbed 
as monomer at pH 8.3 and changes conformtion when ad-
sorbed on high hydrophobic surfaces PVF-CVD. When Zn-
free porcine insulin is adsorbed at pH 4.3, it forms dimers 
and is more stable specie that does not change confor-
mation during adsorption process. 
 
CONCLUSION 
In this work a surface-MALDI-TOF-MS method for studying 
adsorption of zinc free porcine insulin onto different PVDF 
surfaces was described. By means of this technique it is pos-
sible to determine Zn-free porcine insulin behaviour during 
adsorption onto material surfaces and to analyse structural 
stability of these surface bound molecules. The strong in-
teraction of Zn-free porcine insulin which was dissolved in 
a carbonate buffer pH 8.3 with the hydrophobic surface is 
accompanied by a reduction in ability of the MALDI-matrix 
solution to desorb and encapsulate insulin molecules. As 
the result the degradations products of insulin were de-
tected in surface spectra. The Zn-free porcine insulin ad-
sorbed more strongly onto high hydrophobic PVDF-CVD 
surface in comparison to less hydrophobic PVDF surface. By 
dissolving Zn-free porcine insulin in deionised water at high 
concentration, the protein molecules form dimer which, 
during MALDI procedure, are desorbed from the surface 
and incorporated in the matrix. Thus only the monomer ion 
peaks of porcine insulin were detected. However more de-
tailed determinations and characterisations of the degrada-
tion products as well as association of insulin onto surfaces 
is necessary for a complete understanding of the adsorp-
tion, desorption and ionisation processes. The exact inter-
action between insulin and matrix molecules still remains 
to be resolved. 
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